homocysteine has been researched along with glimepiride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccarelli, L; Crescenzi, G; Derosa, G; Fogari, R; Mugellini, A | 1 |
| Ciccarelli, L; Derosa, G; Fogari, R; Franzetti, I; Gadaleta, G | 1 |
| Abd-Allah, GM; Hassan, MH | 1 |
3 trial(s) available for homocysteine and glimepiride
| Article | Year |
|---|---|
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.
Topics: Blood Glucose; Blood Pressure; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Homocysteine; Humans; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Piperidines; Plasminogen Activator Inhibitor 1; Risk Factors; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2003 |
Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipoprotein(a); Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Sulfonylurea Compounds | 2004 |
Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Folic Acid; Gliclazide; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Risk Factors; Sulfonylurea Compounds | 2015 |